MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Risk of Parkinson’s Disease due to Helicobacter Pylori and High Salt Consumption

    V. Balendra (Park Ridge, USA)

    Objective: The association between excessive salt consumption, susceptibility to H. pylori infection and risk of Parkinson's disease will be analyzed through scientific studies. Background: The…
  • 2023 International Congress

    The Role of Adaptive Immunity caused by α-synuclein Recognition Specific Sequence Peptide on the Onset of Parkinson’s Disease Pathogenesis

    MG. Jo, BN. Lee, HM. Seong, SH. Kim, HN. Choi, MG. Kim, SP. Yun (Jinju, Republic of Korea)

    Objective: We investigated whether α-synuclein-derived peptides (recognized specific sequence in α-synuclein) can drive T-cell response and evaluated the neurotoxicity of α-synuclein peptide-specific T-cell in Parkinson’s…
  • 2023 International Congress

    Potentially inappropriate medication useage among patients newly diagnosed with dementia with Lewy bodies

    K. Wyman-Chick, E. Chrenka, M. Barrett, M. Miller, L. Sargent, J. Kuntz, H. Nguyen, A. Werner, Z. Libert, R. Rossom (St Paul, USA)

    Objective: Investigate the use of potentially inappropriate medications (PIM) among patients newly diagnosed with dementia with Lewy bodies (DLB). Background: PIM, including anticholinergics, are associated…
  • 2023 International Congress

    Review of NPO status on admitted PD patient outcomes

    R. Martin (Springfield, USA)

    Objective: To characterize the incidence and severity of outcomes for PD patients admitted to the hospital who miss doses of their medication. Background: PD is…
  • 2023 International Congress

    Therapeutic effects of citral nanoliposome on Parkinson’s treatment in a rat model: Modulation via neurochemical, inflammatory and antioxidant pathways

    N. Moradikor, M. Haghipanah, W. Mohamed (Tbilisi, Georgia)

    Objective: The present study aimed to assess the effects of citral nanoliposome on Parkinson's treatment in a rat model. Background: Parkinson's disease is the most…
  • 2023 International Congress

    Strategic decision-making in Parkinson’s disease with fatigue

    C. Pauletti, D. Mannarelli, F. Milano, A. Maffucci, A. Petritis, F. Fattapposta (Rome, Italy)

    Objective: To assess response inhibition and strategic decision-making abilities associated with fatigue in Parkinson’s disease (PD). Background: PD-related fatigue is defined as a feeling of…
  • 2023 International Congress

    Correlation between Motor Sections of UMSARS and MDS-UPDRS

    S. Castillo-Torres, A. Ferreirós, M. Merello (Buenos Aires, Argentina)

    Objective: To determine the correlation between UMSARS II and MDS-UPDRS III. Background: Despite the availability of the Unified Multiple System Atrophy Rating Scale (UMSARS) [1]…
  • 2023 International Congress

    SARS-CoV-2 infection exacerbates the cellular pathology in Parkinson’s disease progression

    HN. Choi, BN. Lee, YH. Che, MG. Ko, HM. Seong, MG. Jo, KS. Lyoo, YJ. Kim, SP. Yun (Jin-Ju, Republic of Korea)

    Objective: This study can provide an important insight for identification and prediction of long term neurological sequelae of SARS-CoV-2 infection and proper clinical management the…
  • 2023 International Congress

    Therapeutic Plasma Exchange in the Management and Outcome of Stiff-Person Syndrome: A Systematic Review

    SK. Kharel, SS. Shrestha, SA. Acharya (Kathmandu, Nepal)

    Objective: In this review article, we'll explore TPE's role in treating Stiff Person Syndrome(SPS) and its outcomes. Background: Rigidity, stiffness, and intermittent spasms of the…
  • 2023 International Congress

    Rare genetic and clinical presentation of SPG7-related Hereditary Spastic Paraplegia.

    J. Hickman, E. Forbes, J. Feuerstein (DENVER, USA)

    Objective: Describe a rare genetic and clinical presentation of SPG7-related Hereditary Spastic Paraplegia. Background: SPG7-related spastic paraplegia (SPG7) is a hereditary spastic paraplegia caused by…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley